Dr. Steve Yang is Vice President, Head of Asia R&D and a member of Pfizer Global R&D’s leadership team. He focuses on developing and implementing Pfizer’s Asia R&D strategy. Prior to his current role, Steve was Head of Research, Asia for Pfizer.  His responsibilities included exploring R&D capabilities of Asia countries, establishing and managing partnerships with biotech companies, academic research institutions, and R&D service providers.  Earlier, Steve was an Executive Director and the global head of Pfizer Global R&D’s Strategic Management Group.  His main responsibilities included providing strategic advice and consulting service to the senior R&D leaders and managing a global team of internal consultants. He received a Pfizer Global R&D Achievement Award in 2003.

Prior to Pfizer, Steve held positions of varying responsibilities at IntraBiotics Pharmaceuticals, an emerging biotech company in California.  Steve also worked for Strategic Decisions Group (SDG), a boutique management consulting firm specialized in strategy consulting for Fortune 100 companies. 

Dr. Yang is the co-founder of the BayHelix Group, a non-profit professional organization of Chinese life science business leaders.

Steve received his PhD in Pharmaceutical Chemistry from University of California, San Francisco. He started his undergraduate study in Fudan University, Shanghai, China and completed his BS Summa Cum Laude in Biology from Michigan Technological University.